Interaction of platelet-resident α6β1 with the disintegrin-cysteine-rich domain of tumor cell-derived ADAM9 also triggers platelet activation, α-granule release and P-selectin exposure, increasing tumor cell extravasation (150). The gene discussed is ADAM9; the disease is neoplasm.